Five New NuvaRing Injury Lawsuits Filed
By Sarah Pierce
As reports of severe NuvaRing side effects continue to grow, so do the number of lawsuits against the contraceptive device’s manufacturers. On July 25, 2012 alone, five NuvaRing injury lawsuits were filed on behalf women who suffered serious, life-threatening blood clots, including deep vein thrombosis and pulmonary embolism, allegedly caused by using NuvaRing. All of the lawsuits name Organon, Merck & Co. and Schering Corp. as defendants, and are seeking damages for economic and non-economic losses, including hospital expenses and future medical expenses. According to the NuvaRing lawsuits, the defendants marketed NuvaRing as being just as safe as other forms of birth control and included a package insert stating the vaginal ring has similar risks to that of birth control pills. However, the safety information provided to consumers was not derived primarily from studies of NuvaRing and, therefore, the package insert accompanying NuvaRing is misleading, the lawsuits say. The Plaintiffs allege the defendants knew but failed to disclose, in violation of federal laws, that NuvaRing has a higher risk of thromboembolic complications, including pulmonary embolism, deep vein thrombosis and sudden death compared to oral birth control pills. The NuvaRing lawsuits further charge the companies with failing to warn of the serious risks associated with NuvaRing and for failing to conduct appropriate testing of NuvaRing. As a result of this neglect, the Plaintiffs suffered intense and excruciating physical pain, ultimately requiring hospitalization for their blood clot injuries.
Updated August 7th, 2012
{loadposition content_postads}
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement
